Michael F Maclean - Net Worth and Insider Trading

Michael F Maclean Net Worth

The estimated net worth of Michael F Maclean is at least $4 Million dollars as of 2024-05-12. Michael F Maclean is the SVP, Chief Accounting Officer of Biogen Inc and owns about 11,634 shares of Biogen Inc (BIIB) stock worth over $3 Million. Michael F Maclean is also the CFO of Avidity Biosciences Inc and owns about 44,093 shares of Avidity Biosciences Inc (RNA) stock worth over $1 Million. Details can be seen in Michael F Maclean's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael F Maclean has not made any transactions after 2024-03-13 and currently still holds the listed stock(s).

Transaction Summary of Michael F Maclean

To

Michael F Maclean Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael F Maclean owns 4 companies in total, including Avidity Biosciences Inc (RNA) , Akcea Therapeutics Inc (AKCA) , and Biogen Inc (BIIB) among others .

Click here to see the complete history of Michael F Maclean’s form 4 insider trades.

Insider Ownership Summary of Michael F Maclean

Ticker Comapny Transaction Date Type of Owner
RNA Avidity Biosciences Inc 2024-03-13 Chief Financial Officer
AKCA Akcea Therapeutics Inc 2020-01-15 Chief Financial Officer
BIIB Biogen Inc 2010-08-02 SVP & Chief Accounting Officer
2021-06-16 director

Michael F Maclean Latest Holdings Summary

Michael F Maclean currently owns a total of 2 stocks. Among these stocks, Michael F Maclean owns 11,634 shares of Biogen Inc (BIIB) as of August 2, 2010, with a value of $3 Million and a weighting of 69.24%. Michael F Maclean also owns 44,093 shares of Avidity Biosciences Inc (RNA) as of March 13, 2024, with a value of $1 Million and a weighting of 30.76%.

Latest Holdings of Michael F Maclean

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIIB Biogen Inc 2010-08-02 11,634 221.50 2,576,931
RNA Avidity Biosciences Inc 2024-03-13 44,093 25.96 1,144,654

Holding Weightings of Michael F Maclean


Michael F Maclean Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael F Maclean has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 9,542 shares on August 2, 2010, which brought Michael F Maclean around $542,463.

According to the SEC Form 4 filings, Michael F Maclean has made a total of 2 transactions in Avidity Biosciences Inc (RNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Avidity Biosciences Inc is the sale of 40,000 shares on March 13, 2024, which brought Michael F Maclean around $980,800.

Insider Trading History of Michael F Maclean

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael F Maclean Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael F Maclean Ownership Network

Ownership Network List of Michael F Maclean

No Data

Ownership Network Relation of Michael F Maclean


Michael F Maclean Owned Company Details

What does Avidity Biosciences Inc do?

Who are the key executives at Avidity Biosciences Inc?

Michael F Maclean is the Chief Financial Officer of Avidity Biosciences Inc. Other key executives at Avidity Biosciences Inc include director & President and CEO Sarah Boyce , Chief Scientific Officer Arthur A Levin , and Chief Human Resources Officer Teresa Mccarthy .

Avidity Biosciences Inc (RNA) Insider Trades Summary

Over the past 18 months, Michael F Maclean made 2 insider transaction in Avidity Biosciences Inc (RNA) with a net sale of 41,616. Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 119,600 shares made by Arthur A Levin , a net sale of 223,092 shares made by Sarah Boyce , and a net sale of 4,129 shares made by W. Michael Flanagan .

In summary, during the past 3 months, insiders sold 265,641 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 265,641 shares. During the past 18 months, 390,502 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 390,502 shares.

Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avidity Biosciences Inc Insider Transactions

No Available Data

Michael F Maclean Mailing Address

Above is the net worth, insider trading, and ownership report for Michael F Maclean. You might contact Michael F Maclean via mailing address: 14 Cambridge Center, Cambridge Ma 02142.

Discussions on Michael F Maclean

No discussions yet.